print header
Print Page

Plenary Speakers:

Session Speakers*:

  • Dr Jonathan Arthur, General Manager, CellBank Australia, Australia
  • Mark Ashton, Manager Innovation and Commercial Development, UniQuest, Australia
  • Geoff Bell, Chief Executive Officer, Microbiogen Australia
  • Doron Ben-Meir, Chief Executive Officer, Commercialisation Australia, Australia
  • Hershel  Berry, Managing Partner, Blueprint Life Sciences, United States
  • Warren  Bingham, President - Australia & NZ, Given Imaging, Australia
  • David Blake, Co-Founder, Bioshares, Australia
  • Eric Boone, Partner, Baker & McKenzie, Australia
  • Dr Ben Borson, Attorney, Borson Law Group, United States
  • Dr Arthur Brandwood, Founder & CEO, Brandwood Biomedical, Australia
  • James Brennan, Business Development Manager, Design + Industry, Australia
  • Paul Brennan, Marketing Director ANZ Healthcare Division, Smith & Nephew Pty Ltd Australia
  • Adj Professor Don Bursill AM, Chief Scientist of South Australia, Australia
  • Matthew Callahan, Chief Executive Officer, iCeutica Inc, Australia
  • Peter Chesworth, General Manager, Department of Innovation, Canberra, ACT
  • Dr John Chiplin, Managing Director, Newstar Ventures, Australia
  • Samantha Cobb, Chief Executive Officer, AdAlta, Australia
  • Dr Greg Collier, Managing Director, Barwon Biotechnology, Australia
  • Dr Anne Collins, Associate Director One 2 One Biosciences, Hospira Adelaide, Australia
  • Dr Justin Coombs, Head of Agriculture, TPI Enterprises, Australia
  • Ned Coten, Managing Director, Acorn Brand Design, Australia
  • Dr Rob Crombie, Managing Director, Concept2Clinic Consulting, Australia
  • Glenn Cross, Chief Operating Officer, AusBiotech, Australia
  • Dr Rosalie Cull, Managing Director, TudorRose Consulting, Australia
  • Dr Geoff Cumming, Chief Executive Officer, Anteo Diagnostics, Australia
  • Professor Rocky De Nys, School of Marine and Tropical Biology, James Cook University, Australia
  • Simon De Young, Partner, Baker & McKenzie, Australia
  • Dr Janette Dixon, Vice President Global Business Development, QRx Pharma
  • Trent Donnelly, Director Corporate Finance, E.L & C. Baillieu Stockbroking Australia
  • Dr Ian Dry, Principal Research Scientist, CSIRO Plant Industry Division, Australia
  • Dr Leigh Farrell, VP Business Development, Biota Holdings Limited, Australia
  • Dr David Fisher, Partner, Brandon Capital, Australia
  • Dr Peter French, CEO, Benitec Limited, Australia
  • Dr David Fuller, Chief Operating Officer / Chief Medical Officer, INC Research, Australia
  • Clarke Futch, Managing Director, Cowen Healthcare Royalty Partners, United States
  • Dr Joshua Funder, Partner, GBS Venture Partners, Australia
  • Robert Gay, Director Manufacturing, Cephalon Australia Pty Ltd
  • Dr Harvey Glick, Senior Director, Scientific Affairs Asia, Monsanto, Singapore
  • Marc Goemans, Senior Director New Business Development Asia – Pacific, DSM Biologics, Netherlands
  • Lawrence Gozlan, Chief Executive Officer, Scientia Capital, Australia
  • Hans-Peter Grau, Vice President Business Development, Boehringer Ingelheim Pharma GmbH & Co. KG, Germany
  • Dr Simon Green, Senior Vice President Global Product Development, CSL Limited, Australia
  • A/Professor John Greenwood, Director Burns Unit, The Royal Adelaide Hospital, Australia
  • Associate Professor Ben Hankamer, Institute for Molecular Bioscience, University of Queensland, Australia
  • David Harrison, General Manager, Brandwood Biomedical, Australia
  • Dr Jenny Harry, CHief Executive Officer and Managing Director,Tyrian Diagnostics, Australia
  • Dr Mark Harvey, Partner, CM Capital, Australia
  • Dr Suzanne Hasthorpe, Manager, Coordinating Office for Human Research Ethics , Department of Health, Victoria , Australia
  • Dr Robyn Heath, Senior VP Product Development, Hexima Limited, Australia
  • Dr Mike Hirshorn, Director, Four Hats Capital, Australia
  • T. Justus Homberg, Founder and Executive Director, YHI Ventures, Australia
  • David Hughes, Chief Executive Officer, Biopharmaceuticals Australia, Australia
  • Terry Hurst, Qpharm, Australia
  • Becky Hyde, Chief Marketing Officer, Horizon Science Pty Ltd, Australia
  • Dr Dianne Jackson-Matthews, Director of Regulatory Affairs, ERA Consulting, Australia
  • Dr Jane Jacobs, Director, Office for Health and Medical Research , Queensland Health, Australia
  • Dr Juan Juttner, Manager Gene Discovery, Grains Research and Development Corporation
  • Anne-Maree Keane, Partner Transaction Advisory Services, Ernst & Young, Australia
  • Professor Brendon Kearney, Chair - Health Policy Advisory Committee, Technology (HealthPACT) & EuroScan International Network
  • Dr Andrew Kelly, Executive Director, BioPacific Ventures , New Zealand
  • Dr Paul Kelly, General Partner, One Ventures, Australia
  • Dr Robert Kilpatrick, CEO, Technology Vision Group, United States
  • Andreas Knaack, Director Biomedical Instruments and Devices, Invetech, Australia
  • Dr Mark Krstic, President, Australian Society of Viticulture and Oenology, Australia
  • Professor Peter Langridge, Chief Executive Officer, ACPFG, Australia
  • Dr Ron Laufer, Managing Director, MedImmune Ventures, United States
  • Ian Lewis, Director, SAMIAN Underwriting, United Kingdom
  • Peter Lewis, General Mananger - Business Development, Hydrix, Australia
  • Dr Terry Longhurst, Manager Strategic Science, Livestock Production Innovation, Meat & Livestock Australia, Australia
  • Dr George Lovrecz, Head of Fermentation Group, Material Science and Engineering, CSIRO , Australia
  • Dr Verna MacErlane, Director of Commercial Operations International, SISTEMIC, Scotland
  • Paul MacLeman, Chief Executive Officer, Genetic Technologies Limited, Australia
  • Liddy McCall, Director, Yuuwa Capital, Australia
  • Dr Kristy McCamley, Intellectual Property Manager & Patent Attorney Research,  Biota Holdings Limited, Australia
  • Rob McInnes, Partner, Intellectual Property and Technology, Dibbs Barker, Australia
  • Matthew McNamara, Chief Investment Officer, IB Australian Bioscience Fund, Australia
  • Dr Jurgen Michaelis, Chief Executive Officer, BioInnovation SA, Australia
  • Professor Michael Miller AO, Chair, ATSE SA Division, Australia
  • Dr Jo Mitchell, Assoc Director Research, Ethics and Public Health Training, New South Wales Health, Australia
  • Lisa Nelson, Business Development Manager, Nucleus Network, Australia
  • Dr Ian Nisbet, Founder & Partner, Afandin Pty Ltd, Australia
  • Dr Sarah Norris, Co-Director, Health Technology Analysts, Australia
  • Dr Anthony Filippis, Partner, Afandin Pty Ltd, Australia
  • Kim O'Connell, Partner, Mallesons Stephen Jacques, Australia
  • Dr Esra Ogru, Chief Executive Officer, Phosphagenics, Australia
  • Dr Tim Oldham, Corporate Vice President and President, Asia Pacific, Hospira, Australia
  • Eugene Ong, Lead Sales Manager, Ansarada, Australia
  • Patricia Osidacz, Senior Sensory Scientist, The Australian Wine Research Institute, Australia
  • Naomi Pearce, IP Director & Counsel, Hospira, Australia
  • Dr Jenny Petering, Partner, FB Rice, Australia
  • Dr Susan Pond, Dow Sustainability Program, United States Studies, Australia
  • Dr Kishore Prayaga, Product Development Manager (ANZ), Pfizer Animal Health Asia Pacific, Australia
  • Professor Sakkie Pretorius, Managing Director, The Australian Wine Research Institute, Australia
  • Professor Stephen Prowse, CEO , CRC for Wound Management, Australia
  • Michael Quinn, Managing Partner, Innovation Capital, Australia
  • Professor Roger Reddel, Director, Children's Medical Research Institute, Australia
  • Dr Alan Robertson, Chief Executive Officer, Pharmaxis, Australia
  • Dr Klaus B. Schoepe, Senior Vice President Client Relations, Rentschler Biotechnologie Gmbh, Germany
  • Brendan Shaw, Chief Executive, Medicines Australia, Australia
  • Dr William Shen, Partner, venbio, United States
  • Kym Short, Clinical Project Manager, AstraZeneca, Australia
  • Professor Robert Short, Director of the Mawson Institue, University of SA, Australia
  • Dr William Sietsema, Vice President Global Regulatory Consulting & Submissions, INC Research, United States
  • Dr Richard Soll, Senior Vice President of Integrated Services, WuXi AppTec, China
  • Dr German Spangenberg, DPI, Victorian Government, Australia
  • Shane Storey, Senior Research Analyst, Wilson HTM, Australia
  • Joe Sum, Vice President, Biotechnology Value Fund, United States
  • Dr Anthony Sun, Principal, Aisling Capital , United States
  • Dr Alex Szabo, Principal, Golden Gate Life Sciences Partners, Australia
  • Professor Mark Tester, VP, Company Director & Co-Founder, BIOCONST Pty Limited
  • Ian Thompson, Managing Director, Amgen Australia
  • Dr Alexandra Tickle, Commercialisation Manager, Otago Innovation, New Zealand
  • Dr Richard  Treagus, Chief Executive Officer, Acrux, Australia
  • Cameron Turner, Innovation and Commercial Development Manager, UniQuest, Australia
  • Dr Meera Verma, Director Site Operations, Hospira, Australia
  • Dr Stewart Washer, Investment Committee, IB Fund, Australia
  • Karen West, Senior Director Clinical Operations Asia Pacific, INC Research
  • Nicole Williamson, Senior Technology Manager - Sustainable Aviation Fuel, Boeing Research and Technology Australia
  • Michael Wonder, Wonder Drug Consulting, Australia
  • Dr Graeme Woodrow, Director, Health Technologies Strategy, CSIRO, Australia
  • Nick Woolf, CFO VP Corporate Development Phylogica, Australia
  • Dr Stella Xu, Regional Head, Greater China and Southeast Asia, Roche Partnering, China

* confirmed from September - subject to change

AusBiotech thanks the following event partners:


BioInnovations celbrating 20 years

 

The Business Matching Program is powered by